NY regulators explain Dutrow license revocation


Rick Dutrow (AP Photo-Ed Betz)
Rick Dutrow (AP Photo-Ed Betz)

NEW YORK (Oct. 13, 2011) — The New York State Racing and Wagering Board Wednesday unanimously approved the revocation of trainer Richard E. Dutrow, Jr.’s license. The Board also voted to fine Mr. Dutrow a total of $50,000 for violations relating to a post-race positive of one of his horses and the unlicensed possession of hypodermic syringes.

The 10-year ban and $50,000 in fines represent one of the most significant cumulative penalties issued by the New York State Racing and Wagering Board to a licensee.

“New York’s racing industry has no place or patience for Mr. Dutrow,” Chairman Sabini said. “His repeated violations and disregard of the rules of racing has eroded confidence in the betting public and caused an embarrassment throughout the industry. In order to ensure integrity and honesty in the sport of kings in New York, the Board acted appropriately in barring Mr. Dutrow from participating. His self-described “game‟ in New York horse racing is over. We will not permit individuals who cheat and sully New York’s world-class racing product.”

The Racing and Wagering Board’s Hearing Officer indicated that Mr. Dutrow “is a person whose conduct at racetracks in New York state and elsewhere, has been … unbecoming and detrimental to the best interests of racing…”

The Racing and Wagering Board’s decision resolves two specific matters that arose in November 2010, the latest in a string of violations by Mr. Dutrow:

On November 3, three unlabeled syringes containing the drug xyzaline (a/k/a rompum) were found in Mr. Dutrow‟s desk in Barn 10 at Aqueduct Racetrack. Xyzaline is an analgesic and tranquilizer that can enhance performance by alleviating lameness or calming a nervous horse.

On November 20, “Fastus Cactus,” a horse trained by Mr. Dutrow, competed in the third race at Aqueduct Racetrack with the drug butorphanol (a/k/a torbugesic) in its system. Butorphanol is 10 times more potent than morphine. It is intended to act as a narcotic pre-anesthetic to sedate a horse for a joint examination or pain killer for horses with severe colic. It can affect the performance of a horse by blocking pain and act as a quieting agent for nervous horses.

The Board also considered Mr. Dutrow‟s violation-laden history in making its decision. Since 2003, Mr. Dutrow has been fined and/or suspended for numerous drug violations, including:

2003: 45-day suspension and $3,000 fine for mepivacine violation 2004: 15-day suspension and $2,000 fine for clenbuterol violation 2008: 15-day suspension for clenbuterol violation in Kentucky

In Florida, Mr. Dutrow has faced penalties for numerous violations regarding the use of phenylbutazone. Further, an examination of Mr. Dutrow’s racing application history and rulings demonstrates that he consistently failed to abide by racing rules and was repeatedly untruthful with regulators in various states, including falsified license applications in California (1979), Kentucky (1995) and Delaware (2000). Kentucky has already barred Mr. Dutrow from participating in racing.

In addition to the license revocation, the Racing and Wagering Board assessed two fines on Mr. Dutrow: $25,000 for the butorphanol violation and another $25,000 for the possession of hypodermic syringes.

The Board reached its decision unanimously at its October 12 meeting in Schenectady. Mr. Dutrow‟s license is revoked, effective October 18 in order to allow the transfer of any horses under his care to another trainer.

The Board’s Finding and Order, which includes the Hearing Officer’s Report, is available by clicking here (pdf).

Source: Press Release

Leave a Comment

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s